Analysts’ Updated EPS Estimates for July 2nd (ACHC, ANVS, ARCT, BA, BJRI, BLK, CAPR, CGTX, CML, CNVS)

Analysts’ updated eps estimates for Tuesday, July 2nd:

Acadia Healthcare (NASDAQ:ACHC) had its neutral rating reissued by analysts at Cantor Fitzgerald. They currently have a $90.00 price target on the stock.

Annovis Bio (NYSE:ANVS) had its buy rating reaffirmed by analysts at Rodman & Renshaw. The firm currently has a $67.00 target price on the stock.

Arcturus Therapeutics (NASDAQ:ARCT) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $60.00 target price on the stock.

BAE Systems (LON:BA) had its overweight rating reiterated by analysts at JPMorgan Chase & Co.. JPMorgan Chase & Co. currently has a GBX 1,500 ($18.97) price target on the stock.

BJ’s Restaurants (NASDAQ:BJRI) had its outperform rating reiterated by analysts at Wedbush. They currently have a $43.00 price target on the stock.

BlackRock (NYSE:BLK) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $915.00 price target on the stock.

Capricor Therapeutics (NASDAQ:CAPR) had its buy rating reissued by analysts at HC Wainwright. They currently have a $40.00 price target on the stock.

Cognition Therapeutics (NASDAQ:CGTX) had its buy rating reiterated by analysts at Rodman & Renshaw. Rodman & Renshaw currently has a $14.00 price target on the stock.

CML Microsystems (LON:CML) had its house stock rating reiterated by analysts at Shore Capital.

Cineverse (NASDAQ:CNVS) had its speculative buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $9.00 target price on the stock.

Core Scientific (NASDAQ:CORZ) had its buy rating reiterated by analysts at LADENBURG THALM/SH SH. They currently have a $14.50 target price on the stock.

Craneware (LON:CRW) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 2,600 ($32.89) price target on the stock.

Dayforce (NYSE:DAY) had its neutral rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $68.00 target price on the stock.

Devolver Digital (LON:DEVO) had its buy rating reaffirmed by analysts at Shore Capital.

DSW Capital (LON:DSW) had its house stock rating reaffirmed by analysts at Shore Capital.

Emergent BioSolutions (NYSE:EBS) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $8.00 target price on the stock.

Expedia Group (NASDAQ:EXPE) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $180.00 target price on the stock.

Floor & Decor (NYSE:FND) had its outperform rating reissued by analysts at Robert W. Baird. They currently have a $127.00 target price on the stock.

General Dynamics (NYSE:GD) had its outperform rating reiterated by analysts at Robert W. Baird. The firm currently has a $345.00 target price on the stock.

GeoVax Labs (NASDAQ:GOVX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 price target on the stock.

GSK (LON:GSK) had its underweight rating reaffirmed by analysts at JPMorgan Chase & Co..

HCA Healthcare (NYSE:HCA) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $335.00 target price on the stock.

Harley-Davidson (NYSE:HOG) had its outperform rating reissued by analysts at Robert W. Baird. The firm currently has a $40.00 price target on the stock.

Werewolf Therapeutics (NASDAQ:HOWL) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $15.00 target price on the stock.

Hummingbird Resources (LON:HUM) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 18 ($0.23) price target on the stock.

Humacyte (NASDAQ:HUMA) had its buy rating reiterated by analysts at Benchmark Co.. They currently have a $15.00 target price on the stock.

Humacyte (NASDAQ:HUMA) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $7.00 price target on the stock.

IceCure Medical (NASDAQ:ICCM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $3.00 target price on the stock.

Impact Healthcare REIT (LON:IHR) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. They currently have a GBX 114 ($1.44) target price on the stock.

Incyte (NASDAQ:INCY) had its underperform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $48.00 target price on the stock, down from their previous target price of $52.00.

Insmed (NASDAQ:INSM) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $70.00 target price on the stock.

Inozyme Pharma (NASDAQ:INZY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $14.00 price target on the stock.

Kitwave Group (LON:KITW) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 455 ($5.76) price target on the stock.

Lennar (NYSE:LEN) had its neutral rating reiterated by analysts at Citigroup Inc.. They currently have a $164.00 target price on the stock, down from their previous target price of $174.00.

Mercia Asset Management (LON:MERC) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 64 ($0.81) price target on the stock.

Ovid Therapeutics (NASDAQ:OVID) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $3.00 target price on the stock.

Porch Group (NASDAQ:PRCH) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $3.75 target price on the stock.

Peloton Interactive (NASDAQ:PTON) had its market perform rating reaffirmed by analysts at JMP Securities.

R1 RCM (NASDAQ:RCM) had its outperform rating reaffirmed by analysts at Robert W. Baird. Robert W. Baird currently has a $18.00 price target on the stock.

R1 RCM (NASDAQ:RCM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $20.00 target price on the stock.

Ralph Lauren (NYSE:RL) had its hold rating reaffirmed by analysts at Argus.

Rentokil Initial (LON:RTO) had its neutral rating reiterated by analysts at JPMorgan Chase & Co.. The firm currently has a GBX 500 ($6.32) price target on the stock.

Ryan Specialty (NYSE:RYAN) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $62.00 target price on the stock.

J Sainsbury (LON:SBRY) had its house stock rating reaffirmed by analysts at Shore Capital.

J Sainsbury (LON:SBRY) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. They currently have a GBX 300 ($3.79) target price on the stock.

Surgery Partners (NASDAQ:SGRY) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $43.00 price target on the stock.

Schneider National (NYSE:SNDR) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $27.00 price target on the stock.

SoFi Technologies (NASDAQ:SOFI) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $10.00 target price on the stock.

Supreme (LON:SUP) had its house stock rating reissued by analysts at Shore Capital.

Tenet Healthcare (NYSE:THC) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $112.00 target price on the stock.

Tempur Sealy International (NYSE:TPX) had its buy rating reissued by analysts at Truist Financial Co.. They currently have a $65.00 price target on the stock.

Tesla (NASDAQ:TSLA) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings Inc..

Universal Health Services (NYSE:UHS) had its underweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $162.00 target price on the stock.

WideOpenWest (NYSE:WOW) had its underperform rating reissued by analysts at Raymond James.